Daiichi Sankyo and Ranbaxy Leverage New Business Model with Launch of Evista in Romania

Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited announced today that Terapia S.A., a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista® in Romania.

The details can be read here.